Genetic Predisposition to Disease
69
22
26
26
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 69 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
8%
2 of 26 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 26 completed trials
Clinical Trials (69)
Full-scale Intervention Study: Genetic Risk Communication and Wearables
Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing
Germline Testing for Predisposition to Myeloid Malignancies
Helix Research Network
Microbiome and Association With Implant Infections
The China Neonatal Genomes Project
This Study Consists of Two Study Parts Conducted Under a Single IRB. Part I: Short Term ApoE-dependent Cerebral Blood Flow Response to Sirolimus in Cognitively Normal Adults Part II: Short Term ApoE-dependent Cerebral Blood Flow and Lung Perfusion Response to Sirolimus in Cognitively Normal Adults
Implementation of Whole Genome Sequencing as Screening in a Diverse Cohort of Healthy Infants
Assesment of Multiomics Profiles in Health and Disease.
Healthy Volunteers Study
VIGOR: Virtual Genome Center for Infant Health
Genetic Predisposition to High Blood Pressure
Blood Markers of Early Pancreas Cancer
Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition
Expression of Genes Relating Hypertension and Efficacy of 4-7-8 Breathing Control on Reducing Blood Pressure
Breast Cancer Risk After Diagnostic Gene Sequencing
Return of Genomic Results and Aggregate Penetrance in Population-Based Cohorts
The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer
Genetic Determinants of Kidney Disease in People of African Ancestry With HIV
Evaluating an Alternative Clinical Genetics Cancer Care Deliver Model